Slide 1: 2016 Annual General Meeting
For personal use only 2016 Annual General Meeting Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Uscom Executive Chairman/CEO
Slide 2: Uscom Limited 2016 Annual General Meeting
For personal use only Uscom Limited 2016 ANNUAL GENERAL MEETING
Slide 3: Introduction
Introduction For personal use only Board of Directors: Prof Rob Phillips (Executive) Ms Sheena Jack (Non-executive) Mr Christian Bernecker (Non-executive) Mr David He (Non-executive) Company Secretary – Mr Brett Crowley BDO Auditors – Mr Gareth Few
Slide 4: Agenda
Agenda For personal use only • Quorum / Open meeting • Chairman’s Welcome, Introduction of Board Members • Chairman’s Presentation • Results and operations 2016 • Strategy 2017 • Notice of Meeting – Taken as Read • Consideration of Reports • Business – Resolutions 1 - 6 • Close of Meeting • Question
Slide 5: Executive Chairman's Report
For personal use only Executive Chairman’s Report Associate Professor Rob Phillips PhD(Med), MPhil(Med), FASE, DMU(Cardiol) Executive Chairman, Chief Executive Officer, Head Clinical Science
Slide 6: Uscom - 2016 "Growing as planned!"
Uscom - 2016 For personal use only “Growing as planned!” Uscom – Medical devices the experts use
Slide 7: Uscom - Mission
Uscom - Mission For personal use only "Uscom is a leading innovator in medical devices, developing new technologies to address the challenges of global disease and health care. Uscom is driven by a commercial ambition to become a leader in global health business.” Uscom – Medical devices the experts
Slide 8: 2016 Results
2016 Results For personal use only Growth: Record revenue, sales, cash, share price, cap value (+44 to114%) And investment: Transformational $65m 5yr China agreement Acquired and consolidated Thor laboratories into Uscom One off investments: acquisition and integration (≈$1m) BP+ and SpiroSonic prep
Slide 9: 2016 Results: Total Revenue and Receipts
2016 Results For personal use only Total Revenue Receipts from Customers $3,500,000 2,563,145 2,500,000 $2,936,504 $3,000,000 2,000,000 $2,500,000 $2,039,426 $2,000,000 1,500,000 1,321,080 $ $1,500,000 $1,377,716 1,000,000 $1,010,942 829,424 $1,000,000 $864,099 621,253 500,000 $500,000 $0 - 2012 201
Slide 10: 2016 Results: Quarterly Revenue and Cash Receipts
2016 Results For personal use only Quarterly Total Revenue Quarterly Cash Receipts 900000 700,000 800000 600,000 700000 600000 500,000 500000 400,000 $ $ 400000 300,000 300000 200,000 200000 100000 100,000 0 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 0 Q3 13
Slide 11: 2016 Results: Cash, Equity and Assets
2016 Results For personal use only Cash, Equity and Assets 6,000,000 5,711,746 4,937,991 5,000,000 4,000,000 2,839,773 2,936,355 $ 3,000,000 2015 2016 2,288,661 2,000,000 1,290,796 992,796 1,000,000 526,317 0 Cash Cash Spend Equity Assets A year of investment * Estimate
Slide 12: Announcements 2015
Announcements For personal use only 2015 July • USA FDA Clearance for Thor Ultrasonic Spirometers September • Uscom Completes Thor Acquisition November • Uscom Establishes UK Subsidiary • USCOM can Replace Cardiac Catheters in Children • New SpiroSonic Series of Asthma Products 2016 January • Non-in
Slide 13: Announcements 2016
Announcements For personal use only 2016 February • Uscom Customer Receipts Up 72% In First Half March • Uscom BP+ Contracted Into UK NHS Supply Chain • Former J&J Asia Executive Appointed to Uscom Board • Paediatric sepsis mortality reduced 46% with USCOM use: 11. New Thai critical care study May •
Slide 14: Announcements 2016 - Busy growing
Announcements For personal use only 2016 July • New US Uscom BP+ Patent • Additional Uscom BP+ US Patent October • Uscom Budapest Revenue up 48% pa • Paediatric Sepsis Outcomes Improved With USCOM • CE Mark for New Uscom Asthma and COPD Devices November • Uscom CEO Appointed to Govt China Initiative
Slide 15: Building Great Brands
Building Great Brands For personal use only Uscom – devices the experts use
Slide 16: Building Great Products
Building Great Products For personal use only Uscom – devices the experts use
Slide 17: Building New Markets
Building New Markets For personal use only Telemonitoring asthma and COPD Digital ultrasonic spirometers Wireless connectivity Proprietary apps and software Diagnostic and therapeutic monitoring Leading pulmonary monitors in eHealth 450 sold into the US (2016) Growing global market Uscom Phone App U
Slide 18: Meeting Global Clinical Needs
Meeting Global Clinical Needs For personal use only Uscom addresses conditions responsible for 80% of the leading causes of death worldwide (WHO criteria). Heart failure, sepsis, hypertension, asthma, COPD. Uscom – Medical devices the experts use http://www.who.int/mediacentre/factsheets/fs310/en/ -
Slide 19: Changing outcomes
Changing outcomes For personal use only 36 new publications Outcomes Changes 120 100 100 100 100 100 80 66 % 60 ACCM+echo 50 ACCM+echo + NE/USCOM 42 40 25 20 0 Fluid - 6hrs Fluid Bal 24hrs Invasive Ventilation days PICU days Changing the lives of children with septic shock in India Ranjit S, Natraj
Slide 20: New patents
New patents For personal use only Two new US BP+ patents 1. Central algorithms BP+ 2. Method and apparatus BP+ Notice of Allowance from the United States Patent Notice of Allowance from the United States Patent and Trademarks Office for the patent covering the and Trademarks Office for a patent cove
Slide 21: Global manufacturing
Global manufacturing For personal use only To meet demand. Currently Future USCOM 1A and BP+ in Sydney SpiroSonic and BP+ in Hungary SpiroSonic in Hungary
Slide 22: 2016 Results
2016 Results For personal use only " Investors can review Uscom’s progress in 2016 with satisfaction and look forward to the rewards of 2017 and beyond. Uscom has invested in the future, and investors will share in the profits of this investment as we continue to meet our milestones.” Uscom – Medica
Slide 23: 2017 milestones
2017 milestones For personal use only More products - Global launch BP+ (+2) Global launch SpiroSonic products (+7) More Revenue - Continue USCOM sales growth Global pricing More and better distribution Cross distribute USCOM/BP+/SpiroSonic Reimbursement drive Global operations – Grow US, UK and Bud
Slide 24: China partnerships
China partnerships For personal use only State funded growth CIIC to import $65m of Uscom devices and support regulatory over 5 yrs Health spend from 6-12% of GDP 1.35b population in 31 provinces Revenue targets in China $20m Uscom positioning to grow with China - $20m pa revenue target
Slide 25: Worldwide regulatory
Worldwide regulatory For personal use only The path to global markets Uscom has established in house skills in regulatory approval of medical devices • Europe - CE • China – CFDA • USA - FDA 510k • Multiple small jurisdictions (TGA etc.) CE is also used for other countries as a basis for registratio
Slide 26: Regulatory Jurisdictions
Regulatory Jurisdictions For personal use only Products 2016 2017 CFDA CE FDA CFDA CE FDA 1 USCOM 1A ✓ ✓ ✓ ✓ ✓ ✓ 2 Uscom BP+ ★ ★ ★ ★ ★ ★ 3 Uscom BP+Reporter ★ ★ ★ ★ ★ ★ 4 SpiroSonic Flo ★ ★ ★ ★ ✓ ★ New Products 5 Smart ★ ★ ★ ★ ✓ ★ 6 Mobile ★ ★ ★ ★ ✓ ★ 7 Pro ★ ★ ★ ★ ✓ ★ 8 SpiroReporter ★ ★ ★ ★ ✓ ★ 9
Slide 27: New distribution
New distribution For personal use only Medica – Taking Uscom products to the world Three leading product lines Distribution Agreements 60 55 Global distribution 50 42 130,000 Delegates 40 36 30 23 5,000 Exhibitors 20 12 10 New distributors in advance of 0 regulatory approvals 2013 2014 2015 2016 201
Slide 28: Three global brands
Three global brands For personal use only Science – Manufacture – Regulatory – Market - Revenue Three revenue streams
Slide 29: Revenue model
Revenue model For personal use only Total Revenue 20,000,000 17,500,000 15,000,000 12,500,000 $ 10,000,000 7,500,000 5,000,000 2,500,000 0 2015 2016 2017* 2018* 2019* 2020* $20m revenue by 2020 = 5 year CAGR of 58%
Slide 30: Uscom news!
Uscom news! For personal use only Uscom receives European Award to Develop Lung Cancer Diagnostic “To develop a simple breath test device for early diagnosis of lung cancer and a wide range of viral, microbial, neoplastic (cancer) and genetic diseases.” Total 2.7m Euro (AU$3.8m) 3 year grant from Th
Slide 31: Uscom - 2017
Uscom - 2017 For personal use only "Uscom has acquired global assets to ensure reliable revenue growth and long term profitability. Our strategy is to efficiently deliver the devices we have developed into global markets. Establish a culture of profitable performance and future shareholder dividends
Slide 32: Uscom - 2017 "Continuing to grow as planned"
Uscom - 2017 For personal use only “Continuing to grow as planned” Uscom – Medical devices the experts use
Slide 33: Questions
Questions For personal use only 2016 Annual General Meeting Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Uscom Executive Chairman/CEO